Dong‐Bo Wu

机构：University of Hong Kong

发表论文 13 篇 · 总被引 122 次 · h-index 6

代表论文

• Serum HB crAg is better than HBV RNA and HB sAg in reflecting intrahepatic covalently closed circular DNA (2019 · Journal of Viral Hepatitis · 被引 60)
• Safety and efficacy of sofosbuvir‐based direct‐acting antiviral regimens for hepatitis C virus genotype 6 in Southwest China: Real‐world experience of a retrospective study (2018 · Journal of Viral Hepatitis · 被引 17)
• Distribution and factors associated with serum HBV pregenomic RNA levels in Chinese chronic hepatitis B patients (2020 · Journal of Medical Virology · 被引 13)
• Tenofovir monotherapy versus tenofovir plus entecavir combination therapy in HBeAg‐positive chronic hepatitis patients with partial virological response to entecavir (2019 · Journal of Medical Virology · 被引 11)
• Simple non‐invasive scoring systems and histological scores in predicting mortality in patients with non‐alcoholic fatty liver disease: A systematic review and meta‐analysis (2021 · Journal of Gastroenterology and Hepatology · 被引 7)
• Optimal drug administration manner would rescue partial virological response in chronic hepatitis B patients with entecavir or tenofovir treatment (2020 · Journal of Viral Hepatitis · 被引 6)